New approach boosts HIV prevention pill use in young south african women
NCT ID NCT04038060
First seen May 05, 2026 · Last updated May 06, 2026 · Updated 1 time
Summary
This study tested different levels of support to help young women in South Africa take their daily HIV prevention pills (PrEP) consistently. 360 women aged 18-25 who were sexually active took part. The goal was to see which support strategies worked best to keep them protected from HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wits Reproductive Health and HIV Institute
Johannesburg, South Africa
Conditions
Explore the condition pages connected to this study.